Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares, rose in value, with the stock price down by -8.05% to the previous day’s close as strong demand from buyers drove the stock to $0.78.
Actively observing the price movement in the last trading, the stock closed the session at $0.85. The value of beta (5-year monthly) was 1.36. Referring to stock’s 52-week performance, its high was $2.55, and the low was $0.81. On the whole, DNA has fluctuated by -27.32% over the past month.
With the market capitalization of Ginkgo Bioworks Holdings Inc currently standing at about $1.58 billion, investors are eagerly awaiting this quarter’s results, scheduled for Mar 01, 2024 – Mar 05, 2024.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 223.21M, with a low estimate of 43M and a high estimate of 49.93M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 46.04M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that DNA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of DNA currently trading nearly -23.01% and -33.04% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 29.92, while the 7-day volatility ratio is showing 10.02% which for the 30-day chart, stands at 8.68%. Furthermore, Ginkgo Bioworks Holdings Inc (DNA)’s beta value is 1.44, and its average true range (ATR) is 0.09.
A comparison of Ginkgo Bioworks Holdings Inc (DNA) with its peers suggests the former has fared considerably weaker in the market. DNA showed an intraday change of -8.05% in last session, and over the past year, it shrunk by -35.73%%.
Data on historical trading for Ginkgo Bioworks Holdings Inc (NYSE:DNA) indicates that the trading volumes over the past 3 months, they’ve averaged 24.85 million. According to company’s latest data on outstanding shares, there are 1.53 billion shares outstanding.
Nearly 33.65% of Ginkgo Bioworks Holdings Inc’s shares belong to company insiders and institutional investors own 61.10% of the company’s shares. The stock has fallen by -53.98% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the DNA stock heading into the next quarter.
